fullscreen
ImpactMojoCost Effectiveness 101www.impactmojo.in
ImpactMojo 101 Series · Free Forever
Cost
Effectiveness
101
Getting the Most Good per Rupee — Comparing Interventions on Cost per Outcome, a Foundational Course for Practitioners & Funders in South Asia
Research-BackedSouth Asia Focus100 SlidesFree Access
ImpactMojoCost Effectiveness 101www.impactmojo.in
What We Cover
01
Why Cost-Effectiveness?
Slides 3–11
02
The Family of Methods
Slides 12–20
03
Measuring Costs
Slides 21–29
04
Measuring Effects
Slides 30–38
05
The Cost-Effectiveness Ratio
Slides 39–47
06
Cost-Utility & DALYs
Slides 48–56
07
Time & Discounting
Slides 57–65
08
Comparing Interventions
Slides 66–75
09
Uncertainty & Sensitivity
Slides 76–83
10
Limits & Equity
Slides 84–91
11
Practice & Tools
Slides 92–99
ImpactMojoCost Effectiveness 101www.impactmojo.in
01
Section One
Why Cost-Effectiveness?
ImpactMojoCost Effectiveness 101www.impactmojo.in
Budgets are finite; needs are not
Every development organisation, ministry and funder faces the same wall: there is never enough money to do everything worth doing. Cost-effectiveness is the discipline of choosing well when you cannot fund it all — doing the most good with the resources you have.
The question is not 'Does this programme work?' but 'Does it do more good per rupee than the alternatives we could fund instead?'
The question CEA answersThe question it does not
Which of these does more good per rupee?Is this programme worth doing at all?
What does the upgrade cost per extra unit?Who should receive it?
Where would the next rupee do most?Whether the outcome is the right one to want
The right-hand column is not a gap to be filled by better analysis. Those are value questions, and a ratio cannot settle them — which is why Section 10 exists rather than being an appendix.
The discipline is worth having even where the numbers end up rough. Forcing a team to name the outcome, cost every ingredient and state the comparator usually changes the conversation before any ratio appears.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Every rupee spent is a rupee not spent elsewhere
Opportunity cost
The value of the best alternative you give up when you choose one option. The true cost of funding programme A is the good you could have done with programme B instead.
A health budget spent on a costly tertiary procedure is a budget not spent on the immunisations or bed nets it could have bought. Opportunity cost makes that trade-off visible.
DecisionThe visible costThe opportunity cost
Fund a tertiary cardiac unitThe capital and running budgetThe immunisation rounds not run
Extend a pilot in one districtThe extension budgetA different district that gets nothing
Hire an M&E specialistOne salaryTwo field staff
Do nothing while decidingZero on the ledgerA year of outcomes forgone
The last row is the one that never appears in a budget. Delay is a choice with a cost, and because it is invisible in accounting terms it is systematically under-weighted in committees.
Opportunity cost is defined against the best alternative forgone, not the average one. If you have not identified what that alternative is, you have not yet stated the cost of your choice.
ImpactMojoCost Effectiveness 101www.impactmojo.in
'The most good per rupee'
Two programmes can both be genuinely good and still differ enormously in how much good they buy per rupee. Cost-effectiveness analysis surfaces those differences so scarce funds flow where they help most.
01
MONEY: a fixed budget
02
CHOICE: many worthy programmes compete
03
EVIDENCE: cost per outcome for each
04
DECISION: fund the most outcomes per rupee
StepThe question at that step
A fixed budgetWhat can we actually spend?
Competing worthy optionsWhat are the real alternatives, including current practice?
Evidence on cost per outcomeEstimated how, from where, with what uncertainty?
AllocationWho gains and who loses if we shift?
Step two is where most analyses go wrong. If the option set is drawn up before the analysis, the ratio only ranks what someone already thought of — and the best buy may not be on the list.
Include "do nothing" and "do the current thing better" as options. Both are frequently competitive and both are routinely left out of comparisons of new proposals.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Same budget, very different impact
Imagine ₹10 lakh to spend on reducing child illness. Programme A averts one case for ₹5,000; programme B averts one for ₹500. The same money buys 200 averted cases instead of 20 — a tenfold difference in good done.
200 vs 20
cases averted for the same ₹10 lakh
Illustrative
10×
more impact from the cheaper-per-outcome option
Illustrative figures — but the logic is real: differences between interventions are often this large, not marginal.
Programme AProgramme B
Cost per case averted₹5,000₹500
Cases averted for ₹10 lakh2002,000
Both are genuinely effective?YesYes
Both programmes work. That is what makes the comparison uncomfortable. Cost-effectiveness rarely separates good from bad; it separates good from better, and the loser is usually somebody’s well-run project.
Before accepting a tenfold gap, check that the two ratios were built the same way — same perspective, same outcome definition, same time horizon. Differences of this size are as often methodological as real.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cost-effective is not the same as cheap
Cheapest
Lowest total cost — but may deliver almost nothing. A programme that does little for very little money is not a bargain.
Cost-effective
Most outcome per rupee. A more expensive programme can be more cost-effective if it delivers far more good.
Cost-effectiveness always holds cost and outcome together. Neither number means much alone.
ProgrammeCostOutcomesCost per outcome
Cheapest₹1 lakh5₹20,000
Mid₹5 lakh100₹5,000
Most expensive₹20 lakh800₹2,500
The most expensive programme here is the most cost-effective, by a factor of eight over the cheapest. Total cost tells you what fits the budget; it tells you nothing about value.
The converse trap is just as common in practice: a low unit cost achieved by serving only the easiest cases, which makes the ratio look good and leaves the actual problem untouched.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Where cost-effectiveness shapes decisions
  • Health ministries deciding which treatments a public scheme covers
  • Funders allocating limited grants across many strong applicants
  • NGOs choosing between programme designs for the same goal
  • Global bodies (WHO, World Bank) ranking interventions across diseases
From a panchayat health post to a national budget, the underlying question is identical: where does each rupee do the most?
Who uses itFor what decision
Health ministriesWhich treatments a public scheme covers
India’s HTA agencyAdvice on technologies and their prices
Funders and grant committeesAllocating across strong applicants
NGOsChoosing between designs for one goal
WHO, World Bank, DCP3Ranking interventions across diseases
India has a formal health technology assessment process under the Department of Health Research, which appraises interventions and technologies for public financing — the same logic applied at national scale.
At panchayat or district level the arithmetic is simpler and the discipline is the same: name the options, cost them fully, agree the outcome, and be explicit about who each option reaches.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cost-effectiveness informs; it does not decide
Cost-effectiveness analysis is one input into a decision, not the whole decision. Equity, rights, feasibility and politics all matter too — themes we return to in Section 10.
The aim is not to put a price on a life, but to be honest about the lives a fixed budget can and cannot save.
— a working principle of health economics
CEA suppliesThe decision also needs
Cost per unit of outcomeWhether that outcome is the right goal
A ranking of optionsWho each option reaches
A defensible efficiency caseRights, obligations and law
A basis for reallocationWhether reallocation is politically possible
Present the ratio alongside the other considerations, not before them. A number produced first tends to anchor the discussion, and everything else then argues against it from a weaker position.
The strongest use of CEA in practice is diagnostic: when a programme looks far worse than its peers, the finding is usually a design problem worth fixing rather than a case for closure.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Why this matters acutely in South Asia
Public health spending per person in much of South Asia is among the lowest in the world relative to need, while disease and deprivation burdens are high. The gap between resources and need makes every allocation choice consequential.
When budgets are tight and needs vast, choosing well is not an academic nicety — it is the difference between reaching many more people or far fewer with the same money.
South Asian conditionConsequence for allocation
Low public health spending per headEvery rupee displaces another rupee of care
High disease and deprivation burdenMany interventions are competitive on paper
High out-of-pocket share of health spendingParticipant costs dominate and are rarely counted
Wide district-level variationA national average ratio fits almost nowhere
The third row is the distinctive one. Where households pay a large share of health costs directly, a provider-perspective analysis omits most of what the intervention actually costs society.
It also means that a programme which reduces out-of-pocket spending can be highly cost-effective from a societal perspective and look like pure cost from a provider one.
ImpactMojoCost Effectiveness 101www.impactmojo.in
02
Section Two
The Family of Methods
ImpactMojoCost Effectiveness 101www.impactmojo.in
CEA, CBA and CUA: one family, different units
Economic evaluation comes in three main forms. All compare cost against benefit — they differ in how they measure the benefit, and that choice shapes what you can compare.
01
CEA: benefit in natural units (cases averted)
02
CUA: benefit in DALYs / QALYs
03
CBA: benefit converted into money
MethodDenominatorComparison scopeMain hazard
CEANatural unitsSame outcome onlyCannot compare across outcomes
CUADALYs / QALYsAcross healthWeights embed contested values
CBAMoneyAcross sectorsRequires pricing health and life
Comparison scope and hazard rise together. Each step towards a more universal denominator buys breadth by importing a value judgement into the measurement itself.
Choose the narrowest method that answers your question. Reaching for CBA when everyone shares one outcome adds contestable monetisation and no additional comparison.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cost-Effectiveness Analysis (CEA)
Cost-Effectiveness Analysis
Compares the cost of interventions per unit of a single natural outcome — e.g. cost per case of malaria averted, per child immunised, per additional year of schooling.
Strength: the outcome stays in real, intuitive units. Limit: you can only compare programmes that share the same outcome. Cost per case averted cannot be set against cost per child enrolled.
CEA works whenIt breaks when
All options share one outcomeOptions produce different kinds of good
The outcome is well definedThe unit shifts — "case detected" vs "case cured"
The outcome is what you care aboutIt is a convenient proxy for something else
You are choosing within a sectorYou must choose between sectors
Unit drift is the quiet killer. Two screening programmes reported as "cost per case" may be counting detection and cure respectively, which are separated by an entire treatment cascade.
Define the outcome in one sentence, with its measurement, before collecting any cost data. Doing it afterwards invites defining it to suit the numbers you already have.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cost-Utility Analysis (CUA)
Cost-Utility Analysis
A special form of CEA that measures benefit in a common health-and-quality unit — the DALY or QALY — so that very different health programmes can be compared on one scale.
Because a DALY captures both length and quality of life, CUA lets you ask whether a rupee does more against blindness, diarrhoea or heart disease — comparisons CEA cannot make. We devote Section 6 to it.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cost-Benefit Analysis (CBA)
Cost-Benefit Analysis
Converts all benefits into money, so cost and benefit share the same unit. The result is a net benefit (benefits − costs) or a benefit-cost ratio.
Power: you can compare a road, a school and a clinic on one ledger. Danger: putting a rupee value on health, education or a life forces uncomfortable — and contested — assumptions.
CBA requires pricingMethod usedObjection
A statistical lifeWillingness-to-pay or wage-risk studiesValues scale with income, so poorer lives price lower
A year of schoolingLater earningsReduces education to labour-market return
Environmental damageStated preference surveysHypothetical answers to hypothetical prices
The income objection is the serious one. Willingness-to-pay methods make a life in a rich country worth more than a life in a poor one, and any cross-country CBA inherits that directly.
CBA earns its place where the comparison genuinely spans sectors and no other method can bridge them. It is a poor default choice inside a single sector where CEA would do.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Which method measures what?
MethodBenefit measured inLets you compare
CEANatural units (cases, children, years)Programmes with the same outcome
CUADALYs or QALYsAny health programmes, across diseases
CBAMoney (₹)Anything — health, roads, schools
CMA*(costs only; outcomes assumed equal)Options with identical effect
*Cost-minimisation analysis is the special case where two options give the same outcome, so you simply pick the cheaper.
You need to compareUse
Three designs for raising immunisation coverageCEA — shared natural outcome
A blindness programme against a diarrhoea programmeCUA — DALYs bridge them
A rural road against a district hospitalCBA — only money spans sectors
Two suppliers of an identical productCost-minimisation — effects are equal by assumption
Cost-minimisation is the most misused of the four. It is valid only when effects are genuinely equivalent, and "roughly similar" is not equivalent — it usually means nobody measured the difference.
The choice follows from the comparison you need, not from what data you happen to hold. Fitting the method to available data is how analyses end up answering a question nobody asked.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Pick the method that fits the question
  • Comparing designs for one outcome? → CEA
  • Comparing across different health conditions? → CUA
  • Comparing across sectors (health vs infrastructure)? → CBA
  • Outcomes already known to be identical? → cost-minimisation
The method is not a matter of taste; it follows from what you need to compare and what you are willing to monetise.
Your comparisonMethodWhat you must then supply
Designs for one outcomeCEAOne clearly defined natural unit
Across health conditionsCUADisability or utility weights, and a threshold
Across sectorsCBAMoney values for non-market benefits
Identical effectsCost-minimisationEvidence that the effects really are identical
Every step to a broader method adds a requirement, not just a capability. The right-hand column is what you take on, and each entry is contestable in a way natural units are not.
So the default should be the narrowest method that spans your options. Reaching further buys comparison scope you may not need at a price in defensibility.
ImpactMojoCost Effectiveness 101www.impactmojo.in
All four share one ratio at heart
Despite the different units, every method asks a version of the same thing: how much do we pay for how much good? The numerator is always cost; only the denominator — the outcome — changes.
value = cost / outcome
ImpactMojoCost Effectiveness 101www.impactmojo.in
Different methods, different answers
The same programme can look excellent under one method and mediocre under another, because each weighs outcomes differently. The method is a lens, and lenses shape what you see.
Always report which method you used, and never compare a CEA result for one programme against a CBA result for another. Units must match.
Never compareBecause
A CEA ratio against a CBA ratioDifferent denominators; the units are not commensurable
Provider-perspective against societal-perspective costsOne counts participant costs, the other does not
Ratios using different discount ratesThe rate alone can change the ranking
An average CER against an ICERThey answer different questions
Each row is a live error in published league tables, not a hypothetical. Entries drawn from different studies almost never share perspective, horizon and discount rate unless someone deliberately harmonised them.
When you cannot harmonise, say so and present the entries separately. A table with a footnote about incomparability is more useful than a ranking that implies comparability it does not have.
ImpactMojoCost Effectiveness 101www.impactmojo.in
03
Section Three
Measuring Costs
ImpactMojoCost Effectiveness 101www.impactmojo.in
Costs are harder to measure than they look
The 'cost' of a programme is rarely the figure on the grant agreement. Real cost includes staff time, volunteers, donated goods, shared overheads and the time of the people you serve. Miss these and you flatter the programme.
A good cost estimate is a careful inventory, not a glance at the budget line.
Cost routinely omittedEffect on the ratio
Head-office overheadsUnderstates cost; flatters the programme
Volunteer and community timeHides the true resource use, often substantial
Donated goods and seconded staffMakes a subsidised model look replicable
Participants’ time, fares and lost wagesIgnores the largest cost for the poorest
Capital already ownedTreats an existing building as free
Every omission runs the same direction. There is no common error that overstates cost, which means uncorrected estimates are systematically optimistic rather than merely noisy.
This matters most when comparing an NGO pilot with a government programme: the pilot often runs on donated inputs the state would have to buy, so its ratio does not transfer.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The ingredients (or inventory) method
Ingredients method
Cost estimation that lists every resource an intervention uses — the 'ingredients' — values each at its real price, and adds them up. Also called the inventory method.
01
LIST every resource used (the ingredients)
02
QUANTIFY how much of each
03
PRICE each at its true value
04
SUM to a total programme cost
IngredientPriced at
Staff timeSalary plus benefits, apportioned by time actually spent
Donated goodsMarket price — not zero
Volunteer timeThe wage they forgo, or a local unskilled rate
A building already ownedRental equivalent, or annualised capital cost
A vehicleAnnualised over its useful life, plus running costs
"Priced at its true value" means opportunity cost, not what appeared on an invoice. A resource used here could have been used elsewhere, whether or not anyone paid for it this year.
Annualise capital rather than charging it all to year one. A vehicle bought in the pilot year makes that year’s ratio look terrible and every later year look artificially good.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Direct and indirect costs
Direct costs
Tied straight to delivery: medicines, field staff salaries, training materials, transport to villages.
Indirect costs
Shared support that enables delivery: head-office rent, accounts, IT, management. Must be apportioned, not ignored.
Leaving out indirect costs is the most common way a programme is made to look cheaper than it really is.
Apportioning indirect costBasisDistorts when
By share of direct costSimplestOne programme is capital-heavy
By staff headcountFair for people-heavy supportProgrammes differ in staff intensity
By beneficiary numbersIntuitiveReach varies in effort per person
Not at allCommonAlways — it understates cost
Omitting overheads is the single most common way a cost estimate flatters a programme, and it is usually not deliberate: overheads sit in a different budget line and nobody owns the allocation.
State the apportionment basis. Two organisations using different bases will report different unit costs for identical work, and neither is wrong — but they are not comparable.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Fixed and variable costs
  • Fixed costs do not change with scale — a training centre, a vehicle, the management team
  • Variable costs rise with each unit served — vaccines, stipends, per-child materials
  • Together they shape how cost-per-outcome changes as a programme grows
This is why pilots look expensive: fixed costs are spread over few beneficiaries. Cost per outcome usually falls as you scale — up to a point.
FixedVariable
ExamplesTraining centre, vehicle, management teamVaccines, stipends, per-child materials
With scaleSpread thinner per beneficiaryRise roughly in proportion
At pilot sizeDominate; ratio looks badSmall share
At scaleSmall shareDominate; ratio flattens out
A pilot’s cost per outcome is not a forecast of the scaled programme’s. Reporting the pilot ratio as if it were is one of the most common overstatements in programme costing.
Project the ratio at plausible scale, separating fixed from variable, and show both. Any funder deciding on scale-up needs the second number, and the pilot only tells them the first.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Why cost per outcome falls with scale
Cost per beneficiary as a programme scales (illustrative)
Illustrative
Fixed costs spread over more people, so the curve falls steeply then flattens. Illustrative numbers, but a near-universal shape.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The perspective decides what counts
PerspectiveCounts costs to…Often misses
ProviderThe implementing organisationCosts borne by participants
ParticipantThe beneficiary — travel, time, feesProvider overheads
SocietalEveryone affected — the fullest viewHardest to measure fully
State the perspective up front. A programme that is cheap for the provider may be costly for a poor participant who loses a day's wage to attend.
PerspectiveCountsTypically omits
ProviderWhat the implementer spendsEverything borne by participants
ParticipantTravel, fees, time, lost wagesProvider overheads
Health systemAll public-sector costsHousehold and private costs
SocietalAll costs to anyoneNothing — but is hardest to measure
Perspective is the single most consequential methodological choice and the one most often unstated. A programme that shifts cost onto participants looks efficient from a provider perspective and may not be.
State it in the first line of the methods. Two ratios computed from different perspectives are not comparable, and a reader cannot detect the mismatch unless you say which you used.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Participant costs are real costs
For a daily-wage worker, attending a 'free' health camp can mean lost income, bus fare and childcare. From a societal perspective those are genuine programme costs — and a reason people drop out.
Designs that lower participant costs — doorstep delivery, evening timings, compensation — can improve cost-effectiveness by lifting uptake, not just by spending less.
Participant costTypical size
Lost wages for a dayOften the largest single item for a daily-wage worker
Transport to the facilityDoubles for an accompanying family member
Childcare, or children brought alongRarely counted, always borne
Informal paymentsReal, undocumented, and regressive
Participant costs are the main reason "free" services go unused, and they fall hardest on exactly the people a programme is meant to reach. Omitting them makes uptake look like a behaviour problem.
Design changes that cut participant cost — doorstep delivery, evening timings, a single visit instead of three — often improve the ratio more than any efficiency gain on the provider side.
ImpactMojoCost Effectiveness 101www.impactmojo.in
A typical programme cost breakdown
Illustrative share of total cost by ingredient
Illustrative
Notice overheads and participant time together are nearly a quarter of cost — the very items most often left out.
Drop those slices and the programme looks ~23% cheaper than it really is. Illustrative shares.
Cost lineFrequently excluded?
Direct delivery — staff, materialsNo
Head-office overheadsVery often
Participant time and travelAlmost always
Capital, annualisedOften
The two lines most often dropped are the two hardest to observe from inside the organisation. Overheads sit in another budget; participant costs never appear in any ledger at all.
Together they can be a quarter of true cost, which means an estimate omitting both reports a programme as roughly a quarter cheaper than it is — and the error is one-directional.
ImpactMojoCost Effectiveness 101www.impactmojo.in
04
Section Four
Measuring Effects
ImpactMojoCost Effectiveness 101www.impactmojo.in
Effects: the 'good' you are buying
If cost is the numerator, the effect is the denominator — the outcome the programme produces. Getting it right matters as much as costing, and is often harder.
In CEA the effect stays in its natural unit: a case averted, a child immunised, a TB patient cured, a year of schooling added.
Getting the denominator wrongWhat happens
Counting outputs instead of outcomesCheap per unit, worthless per rupee
Counting reach instead of changeRewards breadth over depth
Using a proxy nobody validatedA ratio precise about the wrong thing
Counting only outcomes you can measureThe programme optimises towards measurability
The denominator does more damage than the numerator. Costing errors move a ratio by tens of per cent; choosing the wrong outcome can move it by an order of magnitude and reverse a ranking.
Ask what would have to be true for this denominator to be the thing you actually care about. If the answer is a long chain of assumptions, cost the chain or move further down it.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Outcomes in their own real units
  • Health: cases averted, deaths prevented, patients cured
  • Education: additional years of schooling, test-score gains
  • Nutrition: children moved out of stunting
  • WASH: people with sustained access to safe water
Natural units are intuitive and trusted by practitioners — but they only allow comparison within the same outcome.
SectorA defensible natural unitA weak one
HealthCases averted, deaths preventedPeople screened
EducationAdditional years of schooling; learning gainsChildren enrolled
NutritionChildren moved out of stuntingSupplements distributed
WASHPeople with sustained safe-water accessTaps installed
Every weak unit in the right-hand column is an output, and every one is cheaper and easier to count. That asymmetry is what pulls programme reporting towards them.
"Sustained" is doing real work in the WASH row. A tap that fails in eighteen months and a tap maintained for a decade are the same output and entirely different outcomes.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Intermediate vs final outcomes
Intermediate outcome
A step on the causal path — bed nets distributed, children dewormed, people trained. Easy to measure, but not yet the thing you ultimately care about.
Final outcome
The end goal — malaria cases averted, lives saved, income raised. Harder to measure, but it is what actually matters.
Outcome levelExampleMeasurable?Meaningful?
OutputNets distributedEasilyOnly if used
IntermediateNets used nightlyWith effortCloser
FinalMalaria cases avertedHardYes
UltimateDeaths prevented, income raisedHardestYes
Measurability and meaning run in opposite directions, which is why programmes drift up the chain towards outputs. It is not dishonesty; it is what the monitoring system can deliver.
Where you must cost an intermediate outcome, state the assumed link to the final one and test it in sensitivity analysis. That converts a hidden assumption into a visible one.
ImpactMojoCost Effectiveness 101www.impactmojo.in
From inputs to impact
01
INPUTS: money, staff, nets
02
OUTPUTS: nets distributed
03
OUTCOMES: nets used nightly
04
IMPACT: malaria cases averted
Costing per output (nets distributed) is cheap to measure but can mislead — a net unused averts nothing. Push toward outcomes and impact where you can.
Cost per…Cheap to measure?Can mislead because
Net distributedYesAn unused net averts nothing
Net used nightlyHarderUsage may not be sustained
Case avertedHardNeeds a counterfactual
Death preventedHardestRare events; large samples needed
Move one step further down the chain than your monitoring system offers. If you can only cost outputs, at least model the step to outcomes explicitly and test the assumed conversion rate.
The conversion rate between output and outcome is usually the largest uncertainty in the whole analysis, and it is usually assumed rather than measured.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Did the programme really cause the effect?
Cost-effectiveness needs the effect caused by the programme — not the total change, some of which would have happened anyway. That requires a credible counterfactual: what would have occurred without it.
Crediting a programme with outcomes it did not cause overstates its cost-effectiveness. This is why rigorous evaluation (RCTs, quasi-experiments) underpins the best cost-effectiveness estimates.
Effect estimateCounterfactualRisk
Before-and-after changeNone — assumes nothing else changedCredits the programme with the trend
Comparison with non-participantsWeak — they differ by selectionSelection bias, usually upward
Quasi-experimentalPlausible, assumption-dependentFails if the assumption fails
RCTStrongMay not transfer to your setting
Without a counterfactual you are dividing cost by the total change, not the programme’s effect. In a setting where the outcome was already improving, that can overstate cost-effectiveness several-fold.
Monitoring data is the most available and the least suitable source. It records what happened to participants, which is not the same as what the programme caused.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Putting cost and effect together
Divide total cost by total effect and you have the headline number: cost per outcome. ₹6 lakh spent to avert 300 cases is ₹2,000 per case averted.
₹6,00,000
total programme cost
Illustrative
₹2,000
per case averted (cost ÷ 300 cases)
ElementValueWhat to check
Total cost₹6,00,000Perspective; overheads; participant time
Effect300 cases avertedAgainst what counterfactual?
Cost per outcome₹2,000Average or incremental?
ComparatorUnstatedThis is the missing piece
A cost-per-outcome figure with no stated comparator is incomplete. ₹2,000 per case averted compared with nothing is a different claim from ₹2,000 compared with the existing programme.
Run the four checks above on any ratio you are handed. Three of them will usually be unanswerable from the document, and that itself tells you how much weight it can bear.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Where effect estimates come from
SourceStrengthCaution
RCT / trialStrong causal estimateMay not transfer to your context
Quasi-experimentReal-world, plausible counterfactualAssumptions can fail
Programme monitoringCheap, availableNo counterfactual
Published meta-analysisPools many studiesSettings differ from yours
An effect estimate is only as good as the evidence behind it. Borrowed effect sizes need a sanity check against your reality.
SourceUse it whenAdjust for
Your own RCTIt exists — rareNothing; this is the best case
RCT from elsewhereContext is broadly similarBaseline burden, prices, delivery quality
Quasi-experimentNo trial is feasibleState and test the identifying assumption
Meta-analysisSeveral studies existHeterogeneity; the pooled estimate may fit nobody
Monitoring dataOnly for costs, not effectsIt has no counterfactual
A pooled meta-analytic effect can be an average of settings none of which is yours. Look at the spread across studies as well as the central estimate, and use the spread in sensitivity analysis.
Whatever the source, carry its uncertainty into the ratio. An effect estimate with a wide confidence interval produces a cost per outcome with a correspondingly wide range, and reporting only the midpoint hides that.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cheap outputs can buy nothing
It is easy to be cost-effective at producing outputs nobody uses. The discipline is to cost what changes lives, not what is easy to count.
— a programme-evaluation maxim
Always ask whether your denominator is a real outcome or a convenient proxy. The choice can swing the ratio by an order of magnitude.
Denominator chosenCost per unitWhat it means
Leaflets printedVery lowAlmost nothing
People trainedLowAttendance, not change
Practice changedHigherThe intended outcome
Health outcome improvedHighestThe thing worth buying
The same programme can report four ratios differing by orders of magnitude, all arithmetically correct, depending only on which row it chose to divide by.
When comparing two published ratios, check the denominator first. Differences in the outcome definition explain more apparent variation between studies than any real difference in efficiency.
ImpactMojoCost Effectiveness 101www.impactmojo.in
05
Section Five
The Cost-Effectiveness Ratio
ImpactMojoCost Effectiveness 101www.impactmojo.in
The cost-effectiveness ratio
Cost-effectiveness ratio (CER)
Total cost divided by total effect — the average cost of one unit of outcome. Lower is better: less money for the same good.
CER = total cost / total effect
CER tells youIt assumes
The average cost of one unit of outcomeThat units are interchangeable
A basis for comparisonThat other entries were built the same way
Whether a programme is worth runningThat the comparator is doing nothing
Nothing about the next unitConstant returns — usually false
Lower is better only within a valid comparison. A lower CER achieved by counting an easier outcome, or by excluding participant costs, is not better value — it is a different measurement.
The fourth row is why the CER cannot guide scale-up decisions. Average cost across everyone reached says nothing about what reaching the next group would cost.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The average ratio compares to doing nothing
The average CER compares a programme against a baseline of doing nothing. It answers: across everyone reached, what did each unit of outcome cost on average?
Useful for a first sense of a programme — but real decisions usually compare options against each other, not against nothing. That needs the incremental ratio.
Average CERICER
Compares againstDoing nothingThe next-best option
AnswersWhat did the whole programme cost per unit?What does the upgrade cost per extra unit?
Right forWhether to run a programme at allChoosing between options
Misused asJustification for an upgradeRarely misused — more often absent
"Doing nothing" is almost never the real alternative. There is usually a current practice, and the honest comparator is that practice rather than an empty counterfactual nobody would choose.
Naming the comparator is half the analysis. Two studies of the same intervention with different comparators will produce different ratios and both can be correct.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The Incremental Cost-Effectiveness Ratio (ICER)
ICER
The extra cost of switching from option B to option A, divided by the extra effect gained. It measures the cost-effectiveness of the upgrade, not the whole programme.
ICER = costA − costB / effectA − effectB
The ICER is incremental, not average. It is the single most important — and most misread — number in the field.
ICER componentWhat to get right
Cost A − Cost BBoth costed on the same perspective and horizon
Effect A − Effect BBoth effects from comparable evidence
The comparator BCurrent practice, not "nothing"
The thresholdStated, justified, and varied in sensitivity analysis
An ICER is a ratio of two differences, so it inherits the uncertainty of both. Small differences in the denominator produce wildly unstable ratios — and when the effect difference is near zero, the ICER is meaningless.
Report the incremental cost and incremental effect separately alongside the ratio. A reader can then see whether the ICER rests on a substantial difference or a rounding error.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Why the increment, not the average, matters
You are rarely choosing between a programme and nothing. You are choosing whether the extra spend on a better option is worth the extra good it buys. The ICER isolates exactly that trade-off.
A new treatment may be excellent on average yet a poor upgrade — if it costs far more than the current one for only a little extra benefit. The ICER catches what the average hides.
CostEffectAverage CERICER vs previous
Do nothing00
Option B₹5,00,000200₹2,500₹2,500
Option A₹8,00,000260₹3,077₹5,000
Option A’s average ratio is ₹3,077 and its incremental ratio is ₹5,000. The decision is about the upgrade, so ₹5,000 is the number that matters — and it is 62% higher than the average suggests.
This gap widens the more effective the baseline option already is. A strong existing programme makes every improvement on it expensive at the margin, which averages conceal entirely.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Comparing two TB-screening strategies
StrategyCostCases detected
B: standard screening₹5,00,000200
A: enhanced screening₹8,00,000260
Difference (A − B)₹3,00,00060 extra
ICER = ₹3,00,000 ÷ 60 = ₹5,000 per extra case detected. The question for the funder: is an extra case worth ₹5,000? Illustrative figures.
Question the funder should then askWhy
Is an extra detected case worth ₹5,000?This is the threshold question
Detected, or treated and cured?Detection without treatment averts nothing
Who are the extra 60 cases?Enhanced screening may reach a different group
Does the ₹5,000 hold at scale?Marginal cost usually rises
The second question is the one that most often changes the answer. A screening upgrade that detects more cases and does not improve linkage to treatment has bought a statistic.
The third matters for equity: if the extra 60 are the hardest to reach, a ratio that looks poor may be exactly the spending a fairness criterion would prioritise.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Is the ICER 'worth it'?
An ICER only means something against a threshold — the most you are willing to pay for one unit of outcome. Below the threshold, the upgrade is judged worthwhile; above it, not.
Thresholds are themselves value judgements, often tied to a country's income. We return to this in Sections 6 and 10 — there is no neutral 'correct' threshold.
Threshold basisProblem with it
1–3× GDP per capitaArbitrary; unrelated to what the budget can afford
What was funded last yearEntrenches historical choices
A published benchmark from elsewhereReflects another country’s budget and burden
Opportunity cost of the actual budgetCorrect in principle, demanding to estimate
The last row is what a threshold is supposed to represent: the health displaced elsewhere when you fund this. Empirical estimates of that displacement come out well below the GDP-based rules of thumb.
WHO has moved away from blanket GDP multiples for exactly this reason. If you use one, say it is a convention rather than a finding, and show the result at other thresholds.
ImpactMojoCost Effectiveness 101www.impactmojo.in
When the choice is obvious
Dominant
An option that costs less and does more dominates — always choose it. No ICER needed.
Dominated
An option that costs more and does less is dominated — drop it from the comparison entirely.
ICERs only matter for the hard middle cases: more cost and more effect, where you must weigh the trade-off.
OptionCostEffectVerdict
Costs less, does moreLowerHigherDominant — adopt, no ICER needed
Costs more, does lessHigherLowerDominated — drop from the comparison
Costs more, does moreHigherHigherCompute the ICER; judge against a threshold
Costs less, does lessLowerLowerICER of the downgrade — a savings question
The fourth row is the uncomfortable one and it is a real decision. Dropping a costly service frees money; whether that is right depends on what the freed money buys, which is again an ICER.
Eliminate dominated options before computing any ICERs. Leaving them in produces ratios against an option nobody should choose, which makes the whole comparison misleading.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Don't confuse average with incremental
Reporting a programme's average cost per outcome when the decision is about an upgrade is a frequent and serious error. It can make a poor-value addition look like a bargain.
Rule: if you are comparing two options, you need the ICER between them — the difference in cost over the difference in effect. Never the two averages.
SituationCorrect number
Should we run this programme at all?Average CER against the status quo
Should we upgrade from B to A?ICER of A versus B
Which of five options?Rank by cost, drop dominated, ICERs along the frontier
Is this a good buy in general?No single number answers this
With more than two options, compute ICERs sequentially along the efficiency frontier — each option against the next cheapest surviving one, not all of them against the cheapest.
Reporting an average where an incremental ratio was needed makes a poor-value addition look like a bargain. It is the most consequential arithmetic error in the field, and it is easy to miss on reading.
ImpactMojoCost Effectiveness 101www.impactmojo.in
06
Section Six
Cost-Utility & DALYs
ImpactMojoCost Effectiveness 101www.impactmojo.in
How do you compare blindness with diarrhoea?
CEA cannot compare a programme that prevents blindness with one that prevents child deaths — the outcomes are in different units. To choose across all of health, you need a common currency of health itself.
That common currency combines two things people care about: how long you live and how well you live. Enter the DALY and the QALY.
ComparisonPossible with
Two malaria programmesCEA — shared unit
Blindness prevention vs child mortalityCUA only
A treatment that extends life vs one that improves itCUA — DALYs combine both
Health vs a rural roadCBA only
The third row is what the DALY was built for. Length of life and quality of life are different goods, and a single measure combining them is the only way to trade one against the other explicitly.
Combining them requires deciding how much a year of impaired health is worth relative to a year of full health — which is precisely the disability weight, and precisely what is contested.
ImpactMojoCost Effectiveness 101www.impactmojo.in
QALYs and DALYs: length × quality of life
QALY
Quality-Adjusted Life Year — a year of healthy life. Higher is better; programmes aim to gain QALYs.
DALY
Disability-Adjusted Life Year — a year of healthy life lost. Higher is worse; programmes aim to avert DALYs.
QALYs count health gained; DALYs count health lost. They are mirror images — do not mix them in one calculation.
QALYDALY
CountsHealth gainedHealth lost
DirectionHigher is betterLower is better
WeightsUtility, 1 = full health, 0 = deathDisability, 0 = full health, 1 = death
Used mostly byHTA agencies — NICE and similarGlobal burden of disease work, WHO
They are near mirror images and are not interchangeable in a calculation. The weights are elicited differently and from different populations, so a QALY figure cannot be read across as DALYs.
India’s health technology assessment work generally uses QALYs and cost per QALY; global disease-burden comparisons use DALYs. Know which your source used before quoting a threshold at it.
ImpactMojoCost Effectiveness 101www.impactmojo.in
What a DALY actually is
DALY
Disability-Adjusted Life Year = Years of Life Lost to early death (YLL) + Years Lived with Disability (YLD). One DALY is one lost year of full health.
DALY = YLL (years of life lost) + YLD (years lived with disability)
Because a DALY is a loss, lower is better and interventions seek to avert DALYs — not accumulate them.
ComponentCalculationSensitive to
YLLReference life expectancy − age at deathWhich reference life table is used
YLDYears with the condition × disability weightThe weight, and duration estimates
DALYYLL + YLDBoth, plus any age-weighting or discounting
Using a single global reference life expectancy is deliberate. It means a death at 30 counts the same everywhere, rather than counting for less in countries where life expectancy is already low.
Interventions are said to "avert" DALYs because a DALY is a loss. A programme that averts 500 DALYs has prevented 500 years of healthy life from being lost — not added 500 years to anyone.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Dying early, and living unwell
YLL
Years of Life Lost: a death at 30 against a life expectancy of 70 loses 40 years. Captures the burden of dying early.
YLD
Years Lived with Disability: years spent in ill-health, each weighted by how disabling the condition is. Captures suffering, not just death.
Together they let a single number reflect both a fatal disease and a chronic, disabling but non-fatal one.
ComponentWhat it measuresDriven by
YLLYears lost to premature deathAge at death against a reference life expectancy
YLDYears lived in ill healthDuration × disability weight
Because YLL is anchored to a reference life expectancy, a death in childhood counts for far more than a death in old age. That is a deliberate value choice built into the arithmetic.
Earlier versions also age-weighted years and discounted them, which weighted mid-life above infancy and old age. The Global Burden of Disease study dropped both, and the change moved disease rankings substantially.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Not all years of illness weigh the same
Each condition carries a disability weight from 0 (full health) to 1 (equivalent to death). A year with a mild condition counts as a small fraction of a DALY; a year with a severe one counts as much more.
These weights come from surveys of how people value health states — they are useful, standardised, and genuinely contested. Whose values, and whose lives, the weights reflect is a real ethical question.
Disability weight questionsWhy it is contested
Whose judgements?General-public surveys, not people with the condition
Do people with a condition agree?Often not — they rate their own state higher
Is a year with disability worth less?Disability-rights scholars argue the premise is wrong
Are they culturally stable?Weights vary between populations surveyed
The disability-rights critique is not a technical objection to be refined away. It says the framework assigns lower value to lives lived with disability, and that this is a moral claim disguised as measurement.
You can use DALYs and hold the critique. What you cannot do is present a cost-per-DALY figure as a neutral fact — the weights are contested values, and honest reporting says so.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cost per DALY averted
Cost-utility analysis divides cost by DALYs averted: cost per DALY averted. Lower means more health bought per rupee, and it works across completely different diseases.
cost / DALYs averted = cost per DALY averted
To compute cost per DALY averted, you needUsually the weak link
Full programme costOverheads and participant costs
Cases averted, causally attributedThe counterfactual
DALYs per caseDisability weights and duration
A time horizon and discount rateBoth frequently unstated
Four estimates multiply into one figure, and the result is quoted as though it were a measurement. Each carries its own uncertainty, and they compound rather than cancel.
This is why a published cost-per-DALY figure should be read as an order of magnitude. Differences of two- or three-fold between studies are common and often methodological.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Some interventions avert DALYs very cheaply
Cost per DALY averted — illustrative ranking (lower = better)
Illustrative; relative ordering only, not exact figures
Bars show relative ordering only. Bed nets and basic vaccines are commonly cited as among the most cost-effective health buys — but treat any precise '$ per DALY' figure with care.
Commonly cited as low cost per DALYCaveat
Childhood vaccinationDepends on existing delivery infrastructure
Insecticide-treated bed netsDepends on local malaria burden
Vitamin A supplementationEffect size debated in recent trials
Every entry is conditional on its setting, and a ranking strips the conditions out. Bed nets are an excellent buy where malaria is endemic and a poor one where it is not.
Treat any precise per-DALY figure with suspicion, especially one quoted with no date, source or setting. The ordering is more robust than the numbers — and it shifts too.
ImpactMojoCost Effectiveness 101www.impactmojo.in
When is a cost per DALY 'good value'?
A widely used rule of thumb judged an intervention cost-effective if its cost per DALY averted was below one to three times a country's GDP per capita. It is convenient — and increasingly criticised as arbitrary.
WHO has moved away from blanket GDP-based thresholds toward context-specific judgement. A threshold is a value choice dressed as a number — treat it as one input, never a verdict.
Threshold claimStatus
"Below 1× GDP per capita = highly cost-effective"A rule of thumb, never an empirical finding
"Below 3× GDP per capita = cost-effective"The same; widely used and widely criticised
"WHO recommends these thresholds"No longer — WHO moved away from blanket multiples
"The threshold reflects what we can afford"Only if derived from the actual budget constraint
A GDP-based threshold rises with national income and has no connection to the health budget. Two countries with the same budget per head and different GDPs would judge the same intervention differently.
Empirical work estimating the health actually displaced by spending has generally produced thresholds well below 1× GDP per capita — meaning the conventional rule approves interventions that displace more health than they add.
ImpactMojoCost Effectiveness 101www.impactmojo.in
07
Section Seven
Time & Discounting
ImpactMojoCost Effectiveness 101www.impactmojo.in
A rupee today is worth more than a rupee next year
Costs and benefits arrive at different times. A rupee in hand today can be invested, can meet an urgent need, and is certain — so we value it more than the same rupee a decade away. Discounting makes future and present values comparable.
This is not about inflation. Even with stable prices, sooner is worth more than later.
FlowYear 0Year 10Discounted at 3%
₹1,00,000 cost₹1,00,000₹1,00,000
₹1,00,000 benefit₹1,00,000About ₹74,400
Discounting is separate from inflation. These are real rupees in both years; the reduction reflects timing alone, not any change in prices.
Get this distinction right before anything else in the section. Analyses that apply a discount rate to nominal figures double-count, and it is a surprisingly common error in programme budgets.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Time preference and opportunity cost
  • Time preference: people generally prefer benefits now to benefits later
  • Opportunity cost of capital: money tied up could have earned a return
  • Uncertainty: the further ahead, the less sure the benefit will arrive
Discounting is how we honour all three — putting flows that occur at different times on one comparable footing.
Reason to discountApplies to money?Applies to health?
Time preferenceYesContested
Opportunity cost of capitalYesNot directly
Uncertainty about the futureYesYes
InflationNo — handle separately in real termsNo
Discounting is not inflation adjustment, and conflating the two is a common error. Work in real terms first, then discount; doing both in one rate double-counts.
The middle column is why discounting money is uncontroversial and discounting health is not. Health cannot be invested at a return, so the strongest argument for the rate does not carry across.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Bringing the future into today's terms
Present value (PV)
What a future cost or benefit is worth today, after discounting. A benefit of X in year t is worth X ÷ (1 + r)^t now, where r is the discount rate.
PV = future value / (1 + r)t
SymbolMeaningWhere mistakes happen
rDiscount rate per yearReal, not nominal
tYears from the presentMid-year vs end-year conventions
PVPresent valueMust be applied to costs and benefits alike
Apply the same rate and convention to both sides. Discounting benefits but not costs, or using different rates for each, produces a ratio that means nothing and is easy to do by accident.
For long horizons some analyses use a declining rate, on the argument that uncertainty about the far future justifies weighting it less harshly than constant compounding implies.
ImpactMojoCost Effectiveness 101www.impactmojo.in
How a discount rate erodes future value
Present value of ₹1,000 received in year t (at 3% and 8%)
Illustrative, standard discounting
At 8%, ₹1,000 in 30 years is worth under ₹100 today. The rate you pick dramatically changes how much the future counts.
₹1,000 received inWorth today at 3%At 8%
Year 10About ₹744About ₹463
Year 20About ₹554About ₹215
Year 30About ₹412About ₹99
At 8%, a benefit thirty years out is worth a tenth of its face value; at 3% it retains over 40%. The same programme can be excellent or worthless depending on a number chosen in a spreadsheet.
This is why prevention, education and climate work fares badly under high rates: costs are immediate, benefits decades away — exactly what discounting penalises.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Choosing the discount rate
Common rates in health and development run around 3% per year, though some analyses use higher. The choice is consequential and partly ethical: a high rate makes long-term benefits almost vanish.
This matters acutely for the climate, for children, and for prevention — programmes whose payoffs land decades away look far worse under a high discount rate. The rate encodes how much we value the future.
RateEffectTypically favours
0%Future counts equallyPrevention, children, climate
3%Common convention in healthBalanced
8–12%Future nearly vanishesImmediate treatment over prevention
The rate is partly an ethical parameter, not only a financial one. A high rate says that a life saved in forty years counts for a fraction of a life saved now, which is a position rather than a calculation.
Report the base case at 3%, and show the result at 0% and at a higher rate. If the decision flips between them, the finding is that the choice depends on the rate — and that should be said plainly.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Should we discount health, not just money?
Convention often discounts both costs and health effects (DALYs, QALYs) — otherwise a calculation could justify delaying every benefit forever. But discounting future lives is philosophically uncomfortable.
Whatever you choose, be explicit and consistent, and test how sensitive your result is to the rate — which is exactly what Section 9 is about.
PositionArgumentProblem
Discount health at the same rate as moneyConsistency; avoids paradoxesDevalues future lives
Discount health at a lower rateHealth cannot be investedCan justify indefinite delay
Do not discount healthAll lives count equallyPostponing every programme looks costless
The "indefinite delay" paradox is the standard argument for discounting health: if future health is not discounted, waiting a year is free, and so is waiting forever.
There is no settled resolution. Convention discounts both at the same rate; the defensible practice is to say which you did and show the result under the alternatives.
ImpactMojoCost Effectiveness 101www.impactmojo.in
How far ahead do you count?
Alongside the rate, you must choose a time horizon — how many years of costs and benefits to include. A prevention programme whose payoffs land over a lifetime looks worthless on a three-year horizon.
Cut the horizon too short and you systematically undervalue prevention and anything slow-burning. State the horizon, and match it to when the real effects actually occur.
HorizonSystematically favoursSystematically penalises
3 years (a project cycle)Treatment, immediate deliveryPrevention, education, infrastructure
10 yearsMost health programmesLong-latency benefits
LifetimePrevention and early-childhood workNothing — but forecasts get shakier
The horizon is usually set by the grant, not by the intervention. A three-year evaluation window on a programme whose payoff lands in adulthood is measuring the wrong period and will report failure.
Choose the horizon from the causal chain and state it. If the funder’s window is shorter, model both and show what the short window omits.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Discounting is an assumption, not a fact
The discount rate is the most powerful, least visible assumption in any long-horizon analysis — small changes swing the conclusion.
— a maxim of cost-benefit practice
Always report your discount rate, justify it, and show the result at alternative rates. Hiding it is a red flag in any analysis you read.
ReportBecause
The base-case rateA reader cannot interpret the result without it
Why that rateConvention, guideline, or funder requirement
Results at alternative ratesShows whether the conclusion is rate-dependent
The time horizon alongside itRate and horizon interact strongly
Rate and horizon must be reported together. A high rate over a long horizon and a low rate over a short one can produce similar present values by entirely different reasoning.
An analysis with a long horizon and no stated discount rate cannot be evaluated at all. Treat the omission as a reason to ask for the model rather than to accept the headline.
ImpactMojoCost Effectiveness 101www.impactmojo.in
08
Section Eight
Comparing Interventions
ImpactMojoCost Effectiveness 101www.impactmojo.in
Why we did all this: to compare
The whole point of standardising costs and effects is to lay interventions side by side and ask where each rupee does most good. Done honestly, the comparison can redirect funding to far higher impact.
But comparison is only as trustworthy as the consistency behind it — same method, same units, same perspective, same discount rate. Compare like with like, or not at all.
For a comparison to be valid, all entries shareOr else
The same methodDenominators are not commensurable
The same perspectiveSome entries count participant cost, others do not
The same discount rate and horizonLong-payoff options are penalised inconsistently
Comparable outcome definitions"Case detected" and "case cured" are not the same unit
Comparable contexts, or stated adjustmentYou are comparing settings, not interventions
Harmonising entries is most of the work in building a league table, and it is the part that gets skipped when ratios are lifted from published papers.
If you cannot harmonise, report the entries with their assumptions attached rather than in a ranked column. A table that looks like a ranking will be read as one.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Ranking interventions by cost per outcome
League table
A ranked list of interventions by their cost-effectiveness ratio — cheapest per unit of outcome at the top — used to guide where to spend next.
League tables are powerful and seductive. Their honesty depends entirely on whether the entries were estimated the same way. A table mixing methods is worse than no table.
League table questionWhat to check
Who built it, and for what decision?The framing shapes what was included
Were entries estimated the same way?Method, perspective, horizon, rate
What is the uncertainty on each?Overlapping ranges make the order meaningless
What is missing from the table?Unmeasured outcomes count as zero
Ranks imply a precision the underlying estimates rarely support. Where confidence intervals overlap heavily, the difference between third and eighth place may be noise.
The fourth question is the most important and the least asked. Anything nobody measured — dignity, cohesion, resilience — is absent from the table and therefore, in effect, valued at zero.
ImpactMojoCost Effectiveness 101www.impactmojo.in
GiveWell-style 'cost per outcome' comparison
Illustrative cost per equivalent outcome across programmes
Illustrative; relative comparison only
Funders like GiveWell rank charities by cost per comparable outcome and direct money to the top. The same logic scales from a global fund to a single grant committee. Figures here are illustrative.
Trustworthy whenCheck
Uncertainty shown per entryOverlapping ranges make the order meaningless
Ranks compress away what would let you disagree. A table of positions and nothing else is an argument, not evidence.
GiveWell publishes its models with the judgement calls visible — the practice to imitate, whatever you make of its conclusions.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Moving money up the league table
If programme A averts an outcome for ₹400 and programme E for ₹7,500, shifting funds from E toward A — where appropriate and feasible — can multiply total impact for the same budget.
But 'shift the money' is rarely so simple: programmes serve different people, places and needs. Cost-effectiveness tells you where to look harder, not always where to cut.
Before reallocating, askBecause
Do they serve the same people?Efficiency gains can come from dropping the hardest to reach
Can the efficient one absorb the money?Absorptive capacity is a real constraint
Does the ratio hold at larger scale?Marginal cost rises as the easy cases are used up
What is lost when the other closes?Staff, trust and reach are not instantly rebuilt
"Shift the money up the table" assumes the top entry can scale at the same ratio. That assumption is usually false, and it is exactly what diminishing returns describes.
Reallocation also has transition costs nobody puts in the model: closing a programme destroys relationships and institutional knowledge that took years to build and will not return if the decision is reversed.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The deworming debate
Mass school deworming became a famous 'best buy' — cheap pills, and one influential study linked treatment to better schooling and later earnings. It topped cost-effectiveness league tables for years.
Then re-analyses and replications questioned the size and durability of those long-run effects. The pills are cheap and safe; the magnitude of the benefit — the denominator — turned out far more uncertain than the rankings implied.
Stage of the deworming debateWhat it established
Original trial and follow-upsLarge long-run schooling and earnings effects claimed
Replication and re-analysisCoding and analytic choices materially changed results
Cochrane-style reviewsLittle consistent effect on nutrition, haemoglobin or school performance
Current positionGenuinely contested; cheap enough that some still recommend it
The honest summary is that the effect size is disputed, not that deworming was debunked. Both overstatements circulate, and the second is now as common as the first once was.
What is not disputed is the mechanism of the failure: an intervention topped league tables for years on an effect estimate that could not bear the weight the ranking put on it.
ImpactMojoCost Effectiveness 101www.impactmojo.in
What deworming teaches about league tables
  • A ranking is only as solid as the effect estimate beneath it
  • A single influential study can move millions — and may not replicate
  • Cheap cost (numerator) cannot rescue an uncertain effect (denominator)
  • Precise-looking ratios can hide enormous uncertainty
The deworming story is not 'CEA is useless' — it is 'never read a league-table rank without its uncertainty'. Which is Section 9.
Lesson from dewormingWhat to do about it
A ranking is only as solid as its effect estimateReport the evidence grade beside the ratio
One influential study can move millionsWait for replication before large reallocation
A cheap numerator cannot rescue an uncertain denominatorSensitivity-test the effect, not just the cost
Precise ratios hide wide uncertaintyPublish the range, not the point
This is not an argument against cost-effectiveness analysis. It is an argument against reporting a point estimate as settled, which is a reporting failure rather than a methodological one.
The same structure recurs whenever a single strong result drives allocation. Ask what would have to be false for the ranking to reverse, and how confident anyone is that it is not.
ImpactMojoCost Effectiveness 101www.impactmojo.in
A ratio from elsewhere may not hold here
Costs, wages, disease burden and delivery systems differ across districts and countries. A cost-effectiveness ratio estimated in Kenya or Bihar will not automatically hold in Odisha or Sindh.
Before borrowing a ratio, ask what would change in your context: input prices, baseline burden, uptake, capacity. Adapt, don't copy.
What differs across settingsEffect on a borrowed ratio
Baseline disease burdenFewer cases to avert → worse ratio
Wage levelsStaff-intensive programmes cost differently
Existing delivery infrastructureMarginal cost is far lower where a system exists
Programme quality at scaleTrial-quality delivery rarely survives scale-up
Baseline burden is the largest single driver and the most forgotten. An intervention that averts many cases where prevalence is high averts few where it is low, at similar cost.
Recost the numerator with local prices and re-estimate the denominator with local burden before borrowing any ratio. Transferring a headline figure unadjusted is not evidence use.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The best buy changes as you scale
A top-ranked intervention does not stay top-ranked forever. As you fund the easiest-to-reach first, the cost of reaching each additional person tends to rise — so even the best buy eventually becomes less cost-effective at the margin.
This is why portfolios beat single 'winners': the right answer is usually to fund the best buy up to a point, then move down the table — not to pour everything into one line.
Coverage reachedWho remainsMarginal cost
First 50%Accessible, willing, near a facilityLow
Next 30%Further away, harder to persuadeRising
Last 20%Remote, mistrustful, hardest to serveOften several times the average
Average cost-effectiveness at 50% coverage says nothing about the cost of the next 10%. Decisions about scale-up need the marginal ratio, and it is almost never the one reported.
This is also where efficiency and equity collide most directly: the last 20% is disproportionately the poorest and most remote, and they are exactly whom the marginal ratio argues against reaching.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Comparing interventions honestly
  • Use the same method, units, perspective and discount rate for every entry
  • Show the uncertainty around each ratio, not just the point estimate
  • State the context each estimate came from
  • Pair the ranking with equity and feasibility, never efficiency alone
PracticePrevents
Same method, units, perspective, rate for all entriesComparing incommensurable numbers
Show uncertainty per entryA spurious ordering
State each estimate’s contextTransferring a ratio that does not hold
Pair the ranking with equity dataEfficiency achieved by not reaching the hardest
Report what could not be quantifiedUnmeasured benefits valued at zero
These five take a page and answer most of the objections in the chapter. None requires additional data collection — only that what was already decided is written down.
If a table cannot satisfy the first row, present the entries as separate case studies rather than as a ranking. The visual form of a ranked column makes a claim the data does not support.
ImpactMojoCost Effectiveness 101www.impactmojo.in
09
Section Nine
Uncertainty & Sensitivity
ImpactMojoCost Effectiveness 101www.impactmojo.in
Every ratio is an estimate, not a fact
A cost-effectiveness ratio is built from uncertain inputs — uncertain costs, uncertain effects, an assumed discount rate. The single number that results looks precise but is not. Sensitivity analysis asks how much it could move.
A point estimate with no uncertainty attached is not a finding — it is an illusion of precision. Demand the range.
Uncertain inputTypical rangeUsually the biggest driver?
Effect sizeWide — from the confidence intervalYes, almost always
Unit costsModerateSometimes
Discount rateA stated set of alternativesYes, for long horizons
Coverage achievedWide at scale-upOften
A point estimate with no uncertainty attached is not a result; it is a claim. Every input above is estimated, and the ratio inherits all of their uncertainty at once.
Sensitivity analysis is also a research-prioritisation tool: whichever input swings the answer most is where better evidence would be worth buying.
ImpactMojoCost Effectiveness 101www.impactmojo.in
One-way sensitivity analysis
One-way sensitivity analysis
Vary one input at a time across a plausible range, holding the rest fixed, and watch how the result moves. It reveals which assumptions the answer hinges on.
If halving the assumed effect doubles the cost per outcome and flips your decision, you have found the input that deserves the most scrutiny — and better data.
VaryPlausible range fromIf the decision flips
Effect sizeThe confidence intervalBuy better effect evidence before deciding
Unit costsObserved variation across sitesCost the specific setting properly
Coverage achievedPilot versus realistic scale-upThe scale-up assumption is the decision
Discount rate0%, base case, higherSay the conclusion is rate-dependent
Use real ranges, not arbitrary ±20%. A range taken from the confidence interval or from observed site variation is defensible; a round percentage chosen for tidiness is decoration.
The right-hand column is the point of the exercise. Sensitivity analysis is a decision tool, not a robustness ritual: it tells you what to do next when the answer is not stable.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Tornado diagram: what moves the answer most
One-way sensitivity: swing in cost per outcome by input (illustrative)
Illustrative
Sorted widest-to-narrowest, the bars form a 'tornado'. Here the effect size dominates — so that is where to invest in better evidence. Illustrative.
Tornado barReading it
Widest bar at the topThe input that drives the answer
Bar crossing the threshold lineThat input alone can flip the decision
All bars narrowThe conclusion is robust — report that
Effect size sits at the top of most tornado diagrams. Better outcome evidence usually buys more decision quality than better cost data.
A tornado where no bar crosses the threshold is a strong result. Robustness is a finding, and it is under-reported because it feels like the absence of one.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Probabilistic sensitivity analysis (PSA)
Probabilistic sensitivity analysis
Assign each uncertain input a probability distribution, then simulate the model thousands of times to produce a distribution of cost-effectiveness results, not a single number.
PSA answers the question decision-makers really have: not 'what is the ratio?' but 'how likely is this option to be the best buy, given everything we don't know?'
One-wayProbabilistic (PSA)
VariesOne input at a timeAll inputs together, from distributions
OutputA range per input; a tornado diagramA distribution of results
AnswersWhich input matters most?What is the probability this is good value?
EffortA spreadsheetA simulation, thousands of runs
PSA answers the question decision-makers actually have. Not "what is the ratio" but "how likely is it that this is worth funding at our threshold" — which one-way analysis cannot deliver.
One-way analysis understates total uncertainty because inputs vary together in reality. Both are worth running: one-way to find the drivers, PSA to size the overall risk.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The cost-effectiveness plane
Plot extra cost (vertical) against extra effect (horizontal) relative to the comparator. The origin is the comparator; an option's position decides whether it is an easy yes, an easy no, or a trade-off.
Lower-right
More effect, less cost — dominant. Adopt it.
Upper-left
Less effect, more cost — dominated. Reject it.
QuadrantCostEffectDecision
Lower rightLessMoreDominant — adopt
Upper leftMoreLessDominated — reject
Upper rightMoreMoreDepends on the threshold
Lower leftLessLessA savings trade-off — depends on the threshold
Most real comparisons land in the upper right, which is why the threshold matters so much: it is the line on the plane that separates yes from no, and it is a value judgement.
When a PSA cloud straddles more than one quadrant, no single ICER describes it. Report the proportion of simulations falling below the threshold instead.
ImpactMojoCost Effectiveness 101www.impactmojo.in
An ICER on the cost-effectiveness plane
Simulated results vs a comparator (origin = comparator)
Illustrative PSA cloud
The scatter (one dot per simulation) shows how wide the uncertainty is. A line from the origin is the willingness-to-pay threshold: dots below it are 'worth it'. Illustrative.
PSA cloud shapeInterpretation
Tight cluster below the threshold lineConfident good value
Wide cloud straddling the lineGenuinely uncertain — report the probability
Cloud spanning quadrantsEven the direction of effect is unclear
The useful output is a probability, not a ratio: "at a threshold of ₹X, this is good value in 78% of simulations" is a statement a committee can act on.
A cost-effectiveness acceptability curve plots that probability across a range of thresholds, which removes the need to commit to one and is often the single most useful chart in an analysis.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Why point estimates mislead
Two interventions can have the same headline ratio while one is a near-certain good buy and the other a coin-toss. The point estimate alone cannot tell them apart; the spread can.
Treat any single '₹X per outcome' as the centre of a range, never the truth. The width of that range is often the most decision-relevant fact in the whole analysis.
Intervention XIntervention Y
Point estimate₹5,000 per outcome₹5,000 per outcome
Plausible range₹4,500–5,500₹900–40,000
Probability below a ₹10,000 thresholdNear certainRoughly a coin toss
Identical headline ratios, entirely different decisions. The point estimate is the least informative number in the analysis and the only one that usually gets quoted.
When a range is wide, the useful action is often to buy better evidence rather than to decide. Sensitivity analysis tells you which piece of evidence would narrow it most.
ImpactMojoCost Effectiveness 101www.impactmojo.in
10
Section Ten
Limits & Equity
ImpactMojoCost Effectiveness 101www.impactmojo.in
Efficiency is one value among several
Cost-effectiveness measures efficiency — outcomes per rupee. But societies also care about fairness, rights, dignity and reaching the worst-off. A perfectly efficient choice can be deeply unjust.
Not everything that counts can be counted, and not everything that can be counted counts.
— commonly attributed to William Bruce Cameron
ValueCan CEA weigh it?
Efficiency — outcomes per rupeeYes — this is what it measures
Fairness in who receivesOnly if you add equity weights
Rights and legal obligationNo — obligations do not depend on ratios
Dignity in how people are treatedNo — process is invisible to the ratio
Political feasibilityNo
A perfectly efficient allocation can be unlawful. Where a right exists — to emergency care, to school — the cost per outcome does not determine whether it must be provided.
The useful posture is that CEA settles one question well and is silent on the others. Trouble starts when silence is read as the others having no weight.
ImpactMojoCost Effectiveness 101www.impactmojo.in
The blind spots of cost per outcome
  • Distribution: a total of outcomes hides who gets them
  • Rights & dignity: some things are owed regardless of efficiency
  • Process: how people are treated, not just the result
  • The hard-to-reach: serving them is costlier — and easily deprioritised
Blind spotConcrete example
DistributionA total of outcomes achieved entirely in accessible districts
Rights and dignityEmergency care owed regardless of the ratio
ProcessTwo programmes, same outcome, one treats people badly
The hard to reachHigher cost per outcome; systematically deprioritised
Each blind spot is structural, not an oversight to be fixed with better data. The ratio is a total divided by a total, and totals cannot express distribution.
Reporting outcomes by group alongside the aggregate ratio costs almost nothing and closes the first and fourth rows. It is the cheapest equity correction available.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cheapest-to-reach is not the same as fairest
Reaching a remote Adivasi hamlet or a person with disability often costs far more per outcome than reaching an accessible town. Pure cost-effectiveness quietly pushes resources away from exactly those who need them most.
Left unchecked, 'value for money' can entrench the very inequities development is meant to undo. This is the central ethical tension of the whole field.
GroupCost per outcomeNeed
Accessible urban householdsLowestLower
Rural, road-connectedModerateModerate
Remote Adivasi hamletsHighestHighest
People with disabilitiesHighestHighest
Cost per outcome and need run in opposite directions, which means unweighted cost-effectiveness is not neutral about equity — it has a systematic direction, and it points away from the worst-off.
This is not an argument against measuring efficiency. It is an argument for never presenting the ranking without the distribution alongside it.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Building fairness into the numbers
One response is equity weighting: counting an outcome for a worse-off person as worth more than the same outcome for someone advantaged, so the analysis rewards reaching the marginalised.
It makes the value judgement explicit rather than pretending efficiency is neutral — but choosing the weights is itself a political and ethical act, not a technical one.
Equity weighting decisionWhat it requires you to state
Who counts as worse-offIncome, caste, disability, geography — on what basis
How much extra weightA number, chosen and defended
Whose judgement sets itA committee, a public process, or an analyst alone
Sensitivity to the weightWhether the ranking survives a different weight
Equity weighting does not remove the value judgement; it makes it visible and arguable. That is its advantage over unweighted analysis, where the judgement is implicit and cannot be challenged.
Distributional cost-effectiveness analysis formalises this by reporting outcomes by group rather than in a single total. It is more work and it answers "for whom" as well as "how much".
ImpactMojoCost Effectiveness 101www.impactmojo.in
Numbers carry hidden value judgements
  • Disability weights embed whose view of a 'good life'
  • Discount rates embed how much we value future generations
  • Thresholds embed what a life or a healthy year is 'worth'
  • The choice of outcome embeds what we decided to count at all
Every one of these is a values choice wearing the costume of arithmetic. Data-literate practice means reading the choices, not just the digits.
Technical choiceThe value it encodes
Disability weightsWhose view of a life worth living
Discount rateHow much future people count
ThresholdWhat a year of health is worth
Choice of outcomeWhat was worth counting at all
PerspectiveWhose costs are real
None of these is derivable from data. Each is a position, defended by convention, and each can flip a ranking — which is why an analysis that reports results without reporting its assumptions is not checkable.
The remedy is not to abandon the method. It is to publish the assumptions prominently and show how the conclusion moves when a reader substitutes their own.
ImpactMojoCost Effectiveness 101www.impactmojo.in
What gets measured gets funded
Cost-effectiveness can only weigh outcomes that someone chose to measure. Benefits that are hard to quantify — dignity, social cohesion, women's voice, ecological resilience — risk being treated as if they were worth zero.
'Not measured' is not the same as 'not valuable'. An analysis that silently drops the unmeasurable will systematically under-fund it. Name what your ratio leaves out.
Hard to quantifyTreated by the ratio as
Dignity in the encounterWorth zero
Women’s voice and agencyWorth zero
Social cohesionWorth zero
Ecological resilienceWorth zero
Institutional capacity builtWorth zero
Omission is not neutrality. A benefit left out of the denominator is treated in the arithmetic exactly as if it had been measured and found to be nothing.
List what you could not quantify, explicitly, next to the ratio. A named omission can be weighed by a decision-maker; an unnamed one has already been decided.
ImpactMojoCost Effectiveness 101www.impactmojo.in
A servant, not a master
Cost-effectiveness is most useful as a discipline of attention — forcing you to be explicit about costs, outcomes and trade-offs — and most dangerous when it becomes the sole arbiter of who gets help.
Best practice: present cost-effectiveness alongside equity, rights and feasibility, and let deliberation — not a single ratio — make the final call.
CEA as a discipline of attention forces you toWhich helps even if the ratio is rough
Name the outcome you are buyingEnds vague goals
Cost every ingredientReveals hidden and donated resources
Name the comparatorMakes the real alternative explicit
State assumptionsConverts disagreement into something arguable
Most of the value arrives before the division. Teams that go through this process usually change the programme design before they ever compute a ratio.
Present the result alongside equity, rights and feasibility, and let deliberation weigh them. A ratio that arrives as a verdict rather than an input has exceeded what the method can support.
ImpactMojoCost Effectiveness 101www.impactmojo.in
11
Section Eleven
Practice & Tools
ImpactMojoCost Effectiveness 101www.impactmojo.in
The data a cost-effectiveness study needs
  • Cost data: a full ingredients inventory, including overheads and participant costs
  • Effect data: a credible, causal estimate of the outcome
  • The comparator: what you are measuring against
  • Assumptions: discount rate, time horizon, perspective — stated openly
Most disputes over a result trace back to one of these four. Pin them down before you compute anything.
Data elementWhere disputes usually arise
Cost inventoryWhat was left out — overheads, donated inputs, participant time
Effect estimateThe counterfactual, and whether it transfers
ComparatorWhether "nothing" or current practice was used
Discount rate and horizonWhether prevention was fairly treated
PerspectiveWhose costs were counted
Most arguments about a cost-effectiveness result are arguments about these five choices, not about the arithmetic. Stating all five up front converts a dispute about numbers into a dispute about assumptions, which is more tractable.
Write them as a table at the front of any analysis you produce. It takes ten minutes and it is the single most useful thing you can do for a reader.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Spreadsheets are enough to start
Most cost-effectiveness analyses begin life in a spreadsheet: costs in one sheet, effects in another, the ratio computed transparently, and a tab for sensitivity analysis. Clarity beats sophistication.
Keep every assumption in a labelled, single cell so a reviewer can change it and watch the result move. An auditable spreadsheet is worth more than a black-box model.
Model disciplineWhy
One assumption per labelled cellA reviewer can change it and watch the result move
No hard-coded numbers in formulasHidden constants are the commonest source of error
Costs, effects and results on separate sheetsKeeps the logic followable
A sensitivity tab from the startRetrofitting one means rebuilding the model
Every source cited in the cell commentProvenance survives staff turnover
Clarity beats sophistication in this field. A transparent spreadsheet a funder can interrogate is worth more than an elegant model nobody outside the team can open.
Build the sensitivity tab first, before the results are known. Doing it afterwards invites choosing the ranges that keep the answer where you already put it.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Habits of a trustworthy analysis
  • State the perspective, comparator, horizon and discount rate explicitly
  • Use the ingredients method — cost everything, including the hidden
  • Report the ICER for choices between options, not just averages
  • Always run sensitivity analysis and show the range
  • Present equity alongside efficiency
HabitTakes
State perspective, comparator, horizon, rateFour lines
Use the ingredients methodA day of inventory work
Report ICERs for choices between optionsOne extra column
Run and show sensitivity analysisA spreadsheet tab
Present equity alongside efficiencyDisaggregating what you already have
None of these requires new data collection. They are disclosure and arithmetic discipline, which is why their absence is a signal about the analysis rather than about the budget behind it.
The CHEERS reporting statement covers all five and more. Running it over your draft before circulation catches most of what a reviewer would otherwise raise.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Red flags when you read a CEA
  • A single ratio with no uncertainty or sensitivity analysis
  • An average ratio where an incremental one was needed
  • No stated perspective or discount rate
  • An effect size from one study, treated as settled
  • A ranking that ignores who is reached and who is missed
Red flagWhat it usually conceals
A single ratio, no rangeA wide uncertainty the author would rather not show
An average where an ICER was neededA poor-value upgrade presented as a bargain
No stated perspectiveParticipant costs excluded
One study, treated as settledAn effect estimate that has not replicated
A ranking with no distributional dataEfficiency gained by not reaching the hardest
These are reading instructions, not accusations. Any one of them can be innocent; what they share is that the missing information is exactly what would let you disagree with the conclusion.
Ask for the model, not the summary. An analyst who will share the spreadsheet is making a different claim from one who will only share the headline figure.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Where to go deeper
ResourceWhat it offers
Drummond et al., Methods for the Economic Evaluation of Health Care ProgrammesThe standard textbook of the field
WHO-CHOICEWHO's database and tools for comparing health interventions
Disease Control Priorities (DCP3)Cost-effectiveness evidence across diseases for low/middle-income settings
GiveWell & the Disease Control Priorities reviewsWorked 'cost per outcome' analyses you can learn from
iDSI Reference CaseA shared standard for credible economic evaluation
SourceBest for
Drummond et al.The standard reference; methods in full
WHO-CHOICEComparable estimates across health interventions
Disease Control Priorities (DCP3)Cost-effectiveness evidence for low- and middle-income settings
CHEERS reporting statementA checklist for what an analysis must disclose
GiveWell’s published modelsWorked examples with the assumptions exposed
CHEERS is the most immediately useful item here for a practitioner. It is a reporting checklist, so you can run it over an analysis you are reading as easily as one you are writing.
GiveWell publishes its spreadsheets, including the judgement calls. Whatever you make of its conclusions, the models are among the clearest available demonstrations of how these choices are actually made.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Pair this with the rest of the 101 Series
Cost-effectiveness sits inside a wider toolkit. It is strongest when fed by good measurement, sound evaluation and honest data.
Pair this deck with ImpactMojo's Data Literacy, Impact Evaluation and Theory of Change 101 courses for the full picture.
ImpactMojoCost Effectiveness 101www.impactmojo.in
If you remember five things
  • Most good per rupee — because budgets are finite and choices have opportunity costs
  • Match the method — CEA (natural units), CUA (DALYs), CBA (money)
  • Use the ICER — the incremental, not average, ratio when comparing options
  • Show the uncertainty — a point estimate alone is an illusion of precision
  • Efficiency is not the only value — weigh equity, rights and dignity too
TakeawayThe mistake it prevents
Most good per rupeeTreating "cheap" as "cost-effective"
Match the methodComparing a CEA ratio with a CBA one
Use the ICERJustifying an upgrade with an average
Show the uncertaintyA point estimate read as a fact
Efficiency is not the only valueA ranking that quietly abandons the hardest to reach
Four of the five are about how a result is reported rather than how it is computed. That is where most of the damage in this field is done, and where most of it can be prevented.
If you take one habit from the deck, take the comparator. Asking "compared with what?" of any ratio you are shown will expose more weak analysis than any other single question.
ImpactMojoCost Effectiveness 101www.impactmojo.in
Cost Effectiveness 101 · Complete
Now ask: the most
good per rupee?
CC BY-NC-ND 4.0·Free Forever·ImpactMojo 101 Series